企業プロフィール
IO Biotech 株価・ニュース・カタリスト
- ティッカー:
- IOBT
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Denmark
株価変動の要因
Current closing-price context is not available for IOBT.
企業概要
事業概要
IO Biotech is an immuno-oncology company focused on cancer vaccines and immune-modulating therapies. Its platform aims to create differentiated immunotherapy in solid tumors.
所在地とセクター分類
Headquartered in Denmark and listed on NASDAQ as an ADR, IO Biotech has a global oncology-biotech profile.
ビジネスモデルの特徴
The company depends on clinical data, immune-response validation, and the ability to create a durable cancer-vaccine platform.
バイオ業界での位置付け
IO Biotech is a catalyst-driven oncology name whose valuation depends on early clinical outcomes.
今後のカタリスト
- IO Biotech’s catalysts are Cylembio and the cancer-vaccine program, especially any update that keeps the immuno-oncology platform moving. The company needs human data to support the thesis.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。